Loading company…
TIRmed Pharma develops topical treatments for mild to moderate eczema.
TIRmed Pharma develops topical treatments for eczema, including TIR-01, a water-based cream for mild to moderate symptoms. Founded in 2018, the company is based in Stockholm, Sweden. In April 2025, it raised EUR 4.3 million in funding co-led by Sciety and Sciety Venture Partners to support clinical research.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in